000 | 01147 a2200325 4500 | ||
---|---|---|---|
005 | 20250518000001.0 | ||
264 | 0 | _c20190910 | |
008 | 201909s 0 0 eng d | ||
022 | _a1875-9114 | ||
024 | 7 |
_a10.1002/phar.2180 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClick, Zach R | |
245 | 0 | 0 |
_aNew Food and Drug Administration-Approved and Emerging Novel Treatment Options for Acute Myeloid Leukemia. _h[electronic resource] |
260 |
_bPharmacotherapy _c11 2018 |
||
300 |
_a1143-1154 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aSeddon, Amanda N | |
700 | 1 | _aBae, Young R | |
700 | 1 | _aFisher, Justin D | |
700 | 1 | _aOgunniyi, Adebayo | |
773 | 0 |
_tPharmacotherapy _gvol. 38 _gno. 11 _gp. 1143-1154 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/phar.2180 _zAvailable from publisher's website |
999 |
_c28840175 _d28840175 |